1. Home
  2. DLPN vs NCEL Comparison

DLPN vs NCEL Comparison

Compare DLPN & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.52

Market Cap

17.8M

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.59

Market Cap

20.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLPN
NCEL
Founded
1996
2008
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
20.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
NCEL
Price
$1.52
$2.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.7K
91.3K
Earning Date
11-12-2025
12-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,371,115.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$0.75
$2.48
52 Week High
$1.88
$7.64

Technical Indicators

Market Signals
Indicator
DLPN
NCEL
Relative Strength Index (RSI) 37.11 N/A
Support Level $1.41 N/A
Resistance Level $1.65 N/A
Average True Range (ATR) 0.09 0.00
MACD -0.02 0.00
Stochastic Oscillator 17.27 0.00

Price Performance

Historical Comparison
DLPN
NCEL

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: